View in EDS HTML Full Text PDF Full Text

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).

Saved in:
Bibliographic Details
Title: Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).
Authors: Derman BA; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA. bderman@bsd.uchicago.edu., Major A; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA., Cooperrider J; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Jiang K; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Ramsland A; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Karrison T; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA., Kubicki T; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Jakubowiak AJ; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
Source: Blood cancer journal [Blood Cancer J] 2024 Oct 07; Vol. 14 (1), pp. 170. Date of Electronic Publication: 2024 Oct 07.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39375362
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Derman+BA%22">Derman BA</searchLink>; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA. bderman@bsd.uchicago.edu.<br /><searchLink fieldCode="AU" term="%22Major+A%22">Major A</searchLink>; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Cooperrider+J%22">Cooperrider J</searchLink>; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Jiang+K%22">Jiang K</searchLink>; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Ramsland+A%22">Ramsland A</searchLink>; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Karrison+T%22">Karrison T</searchLink>; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Kubicki+T%22">Kubicki T</searchLink>; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Jakubowiak+AJ%22">Jakubowiak AJ</searchLink>; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Oct 07; Vol. 14 (1), pp. 170. <i>Date of Electronic Publication: </i>2024 Oct 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39375362
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-024-01156-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 170
    Titles:
      – TitleFull: Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Derman BA
      – PersonEntity:
          Name:
            NameFull: Major A
      – PersonEntity:
          Name:
            NameFull: Cooperrider J
      – PersonEntity:
          Name:
            NameFull: Jiang K
      – PersonEntity:
          Name:
            NameFull: Ramsland A
      – PersonEntity:
          Name:
            NameFull: Karrison T
      – PersonEntity:
          Name:
            NameFull: Kubicki T
      – PersonEntity:
          Name:
            NameFull: Jakubowiak AJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 10
              Text: 2024 Oct 07
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1